| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |